Literature DB >> 16260792

Venous thromboembolism in medical inpatients--the silent epidemic of neglect.

Kyle Perrin, Philip Robinson, Richard Beasley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16260792      PMCID： PMC1275991          DOI： 10.1177/014107680509801103

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  12 in total

Review 1.  Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients.

Authors:  W E Wade; M A Chisholm
Journal:  Thromb Res       Date:  1999-04-01       Impact factor: 3.944

2.  Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines.

Authors:  D M Arnold; S R Kahn; I Shrier
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

3.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

Review 4.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

5.  Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns.

Authors:  Walter Ageno; Alessandro Squizzato; Fabio Ambrosini; Francesco Dentali; Chiara Marchesi; Valentina Mera; Luigi Steidl; Achille Venco
Journal:  Haematologica       Date:  2002-07       Impact factor: 9.941

6.  Physician practices in the prevention of venous thromboembolism.

Authors:  F A Anderson; H B Wheeler; R J Goldberg; D W Hosmer; A Forcier; N A Patwardhan
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

7.  Venous thromboembolic prophylaxis in hospitalized medical patients.

Authors:  Jennifer E Stark; Wanda J Kilzer
Journal:  Ann Pharmacother       Date:  2004-01       Impact factor: 3.154

8.  Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review.

Authors:  Sherali A Rahim; Akbar Panju; Menaka Pai; Jeffrey Ginsberg
Journal:  Thromb Res       Date:  2003       Impact factor: 3.944

9.  Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.

Authors:  Gregory de Lissovoy; Prasun Subedi
Journal:  Am J Manag Care       Date:  2002-12       Impact factor: 2.229

10.  Venous thromboprophylaxis in UK medical inpatients.

Authors:  S T Rashid; M R Thursz; N A Razvi; R Voller; T Orchard; S T Rashid; A A Shlebak
Journal:  J R Soc Med       Date:  2005-11       Impact factor: 18.000
View more
  1 in total

1.  Controversies in thromboprophylaxis for immobile patients secondary to neurological impairment.

Authors:  Tarek A-Z K Gaber; Ashraf Azer
Journal:  J R Soc Med       Date:  2006-09       Impact factor: 18.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.